Photo of Jacob Kamen

Jacob Kamen

  • SR. DIRECTOR RADIATION SAFETY Institutional Biosafety
Print ProfilePrint Profile


  • MS, Columbia University

  • Ph.D., Columbia University


    Dr. Kamen completed his graduate work in the Nuclear Engineering program of Columbia University where he spent several years at the Medical Department of Brookhaven National Laboratory.  At Brookhaven, he was involved in the Body Composition and Boron Neutron Capture Therapy project which was performed in the Medical Research Reactor.  His post-doctoral fellowship was in Radiation Oncology.  He has more than 20 years of experience in the field of Health Physics, at the Columbia University Medical Center, the New York University Medical Center and the Mount Sinai Medical Center.  He has had faculty appointments with Manhattan College, New York University and presently is an Associate Professor of Radiology at Mount Sinai School of Medicine. He was elected as the president of the Greater New York Chapter of Health Physics (GNYCHP) in 2004 and recently as the President of the GNYCHP Executive Council for 2010-2011.  He is board certified by the National Registry of Radiation Protection Technologists (NRRPT) and the American Board of Health Physics (ABHP) as well as the Board of Laser Safety

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Kamen did not report having any of the following types of financial relationships with industry during 2015 and/or 2016: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.

Edit profile in Sinai Central